Developing a Case Study Model for Successful Translation of Stem Cell Therapies

Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private “disease team” partnerships to enable new clinical opportunitie...

Full description

Saved in:
Bibliographic Details
Published inCell stem cell Vol. 6; no. 6; pp. 513 - 516
Main Authors Trounson, Alan, Baum, Elona, Gibbons, Don, Tekamp-Olson, Patricia
Format Journal Article
LanguageEnglish
Published Cambridge, MA Elsevier Inc 04.06.2010
Cell Press
Subjects
Biological and medical sciences
California
Cell differentiation, maturation, development, hematopoiesis
Cell physiology
Cell- and Tissue-Based Therapy - economics
Clinical Trials as Topic
Fundamental and applied biological sciences. Psychology
Humans
Insurance, Health
Legislation, Medical
Models, Econometric
Molecular and cellular biology
Organizational Case Studies
Pluripotent Stem Cells
Public-Private Sector Partnerships
Research Support as Topic
Translational Medical Research
California
Case study
Model study
Stem cell
Online AccessGet full text

Cover

More Information
Summary:Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private “disease team” partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1934-5909
1875-9777
DOI:10.1016/j.stem.2010.05.008